Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats

被引:476
作者
Li, M
Zheng, C
Sato, T [1 ]
Kawada, T
Sugimachi, M
Sunagawa, K
机构
[1] Kochi Med Sch, Dept Cardiovasc Control, Nanko Ku, Kochi 7838505, Japan
[2] Natl Cardiovasc Ctr, Res Inst, Dept Cardiovasc Dynam, Suita, Osaka 565, Japan
关键词
electrical stimulation; heart failure; myocardial infarction; remodeling; vagus nerve;
D O I
10.1161/01.CIR.0000105721.71640.DA
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Diminished cardiac vagal activity and higher heart rate predict a high mortality rate of chronic heart failure (CHF) after myocardial infarction. We investigated the effects of chronic electrical stimulation of the vagus nerve on cardiac remodeling and long-term survival in an animal model of CHF after large myocardial infarction. Methods and Results - Two weeks after the ligation of the left coronary artery, surviving rats were randomized to vagal- and sham-stimulated groups. Using an implantable miniature radio-controlled electrical stimulator, we stimulated the right vagal nerve of CHF rats for 6 weeks. The intensity of electrical stimulation was adjusted for each rat, so that the heart rate was lowered by 20 to 30 beats per minute. The treated rats had significantly lower left ventricular end-diastolic pressure (17.1 +/- 5.9 versus 23.5 +/- 4.2 mm Hg, P < 0.05) and higher maximum dp/dt of left ventricular pressure (4152 +/- 237 versus 2987 +/- 192 mm Hg/s, P < 0.05) than the untreated rats. Improvement of cardiac pumping function was accompanied by a decrease in normalized biventricular weight (2.75 +/- 0.25 versus 3.14 +/- 0.22 g/kg, P < 0.01). Although the 140-day survival of the untreated group was only half, vagal stimulation markedly improved the survival rate (86% versus 50%, P = 0.008). Vagal stimulation therapy achieved a 73% reduction in a relative risk ratio of death. Conclusions - Vagal nerve stimulation markedly improved the long-term survival of CHF rats through the prevention of pumping failure and cardiac remodeling.
引用
收藏
页码:120 / 124
页数:5
相关论文
共 32 条
[1]   VENTRICULAR EFFICIENCY PREDICTED BY AN ANALYTICAL MODEL [J].
BURKHOFF, D ;
SAGAWA, K .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 250 (06) :1021-1027
[2]  
Ceiler D L, 1998, J Card Fail, V4, P131, DOI 10.1016/S1071-9164(98)90254-8
[3]   SINGLE CARDIAC VAGAL FIBER ACTIVITY, ACUTE MYOCARDIAL-ISCHEMIA, AND RISK FOR SUDDEN-DEATH [J].
CERATI, D ;
SCHWARTZ, PJ .
CIRCULATION RESEARCH, 1991, 69 (05) :1389-1401
[4]   A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure [J].
Cohn, JN ;
Tognoni, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1667-1675
[5]   Ventricular remodeling in heart failure [J].
Gaballa, MA ;
Goldman, S .
JOURNAL OF CARDIAC FAILURE, 2002, 8 (06) :S476-S485
[6]   Muscarinic receptors in the failing human heart [J].
Giessler, C ;
Dhein, S ;
Pönicke, K ;
Brodde, OE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 375 (1-3) :197-202
[7]   Efferent vagal fibre stimulation blunts nuclear factor-κB activation and protects against hypovolemic hemorrhagic shock (Publication with Expression of Concern. See vol. 146, 2022) [J].
Guarini, S ;
Altavilla, D ;
Cainazzo, MM ;
Giuliani, D ;
Bigiani, A ;
Marini, H ;
Squadrito, G ;
Minutoli, L ;
Bertolini, A ;
Marini, R ;
Adarno, EB ;
Venuti, FS ;
Squadrito, F .
CIRCULATION, 2003, 107 (08) :1189-1194
[8]  
La Rovere MT, 1998, LANCET, V351, P478
[9]   Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBISII trial [J].
Lechat, P ;
Hulot, JS ;
Escolano, S ;
Mallet, A ;
Leizorovicz, A ;
Werhlen-Grandjean, M ;
Pochmalicki, G ;
Dargie, H .
CIRCULATION, 2001, 103 (10) :1428-1433
[10]   SERIAL ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR GEOMETRY AND FUNCTION AFTER LARGE MYOCARDIAL-INFARCTION IN THE RAT [J].
LITWIN, SE ;
KATZ, SE ;
MORGAN, JP ;
DOUGLAS, PS .
CIRCULATION, 1994, 89 (01) :345-354